Castle Biosciences, Inc. · NASDAQ:CSTL

Oelschlager Kristen M sold 4,152 Castle Biosciences, Inc. shares (Form 4)

Traded Sep 1, 2026 · Filed Sep 3, 2026

On Sep 1, 2026, Oelschlager Kristen M (Chief Operating Officer) sold 4,152 Castle Biosciences, Inc. shares at an average US$33.39 for US$139K under a trading plan, leaving 13,356 shares. Filed Sep 3, 2026 (Form 4).

Sold
4,152 shares
Price
US$33.39 average (US$33.36 to US$34.02)
Value
US$139K
Holding after
13,356 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Operating Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 1, 2026Common StockOption exercise4,152US$3.3817,508Direct
Sep 1, 2026Common StockSale3,952US$33.3613,556Direct
Sep 1, 2026Common StockSale200US$34.0213,356Direct

Source

View original at SEC

Related